Study: RenalGuard Not Superior in Avoiding CIN in High-Risk Cases

A randomized controlled trial showed that RenalGuard is no better than conventional IV hydration at preventing contrast-induced nephropathy in high-risk patients.

Related Keywords

France ,Coll Cardiol ,Jacque Cartier ,York Heart Association ,Study Evaluating ,Protect Patients ,High Risk ,Sarah Mauler Wittwer ,Institut Cardiovasculaire Paris Sud ,New York Heart Association ,Transcatheter Aortic Valve Implantation ,